The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Names Kåre Schultz as President and Chief Executive Officer » FINCHANNEL
Kåre Schultz vil stoppe i Teva efter 2023: “Det bliver nok mere bestyrelsesarbejde”
Serial Problem Solver
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Kåre Schultz - Wikipedia
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Kåre Schultz skuffer en smule med Teva i andet kvartal
Where is Kåre Schultz? | Ctech
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Kåre Schultz fyrer 40 folk om dagen - og det er langtfra slut
Watch CNBC's full interview with Teva CEO Kåre Schultz
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the
Teva CEO steps down, replacement found — MedWatch
Sådan har Teva-aktien udviklet sig under Kåre Schultz
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva Appoints Lundbeck's Schultz as CEO | Ctech
Teva CEO Kare Schultz on coronavirus treatment and a possible second wave
En mand på en – næsten – umulig mission
Kåre Schultz er på vej ud af ledelsen hos Teva — MedWatch
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
End Of Schultz Era Looms For Teva :: Generics Bulletin
Business-update: Kåre Schultz forgyldt med lønforhøjelse på op til 26 mio. kroner